Gianluigi Cetto

917 total citations
43 papers, 675 citations indexed

About

Gianluigi Cetto is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gianluigi Cetto has authored 43 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 13 papers in Pathology and Forensic Medicine and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gianluigi Cetto's work include Lymphoma Diagnosis and Treatment (8 papers), Lung Cancer Research Studies (6 papers) and Cancer therapeutics and mechanisms (5 papers). Gianluigi Cetto is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Lung Cancer Research Studies (6 papers) and Cancer therapeutics and mechanisms (5 papers). Gianluigi Cetto collaborates with scholars based in Italy, United Kingdom and United States. Gianluigi Cetto's co-authors include Felice Pasini, Giovanni Pizzolo, Marco Chilosi, R. Cellerino, Antonio Santo, Vittorio Meneghini, Alberto Ambrosetti, G. Perona, Diego Tummarello and Teodoro Sava and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Gianluigi Cetto

41 papers receiving 633 citations

Peers

Countries citing papers authored by Gianluigi Cetto

Since Specialization

Citations

This map shows the geographic impact of Gianluigi Cetto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianluigi Cetto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianluigi Cetto more than expected).

Fields of papers citing papers by Gianluigi Cetto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianluigi Cetto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianluigi Cetto. The network helps show where Gianluigi Cetto may publish in the future.

Co-authorship network of co-authors of Gianluigi Cetto

This figure shows the co-authorship network connecting the top 25 collaborators of Gianluigi Cetto. A scholar is included among the top collaborators of Gianluigi Cetto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianluigi Cetto. Gianluigi Cetto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease 2012 ·International Immunology ·Rocco Pastano, C. A. Dell’Agnola, Caterina Bason, (unknown), Cristina Rabascio, Antonio Puccetti, Elisa Tinazzi, Gianluigi Cetto, Fedro A. Peccatori, Giovanni Martinelli, Claudio Lunardi	12
2	Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis 2009 ·Medical Oncology ·Maria Bonomi, Rolando Nortilli, (unknown), Teodoro Sava, Antonio Santo, A. Caldara, Gianluigi Cetto	21
3	Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study 2009 ·Annals of Oncology ·Luigi Celio, Cora N. Sternberg, Roberto Labianca, Ignazia La Torre, Vito Amoroso, Carlo Barone, G. Pinotti, Stefano Cascinu, Francesco Di Costanzo, Gianluigi Cetto, E. Bajetta	16
4	Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone 2008 ·Urologic Oncology Seminars and Original Investigations ·Orazio Caffo, Teodoro Sava, Evi Comploj, (unknown), (unknown), F. Valduga, Gianluigi Cetto, Enzo Galligioni	18
5	Docetaxel, with or without estramustine phosphate, as first‐line chemotherapy for hormone‐refractory prostate cancer: results of a multicentre, randomized phase II trial 2008 ·British Journal of Urology ·Orazio Caffo, Teodoro Sava, Evi Comploj, (unknown), Fable Zustovich, (unknown), Cosimo Sacco, F. Valduga, Gianluigi Cetto, Enzo Galligioni	28
6	Identification of Clinical Prognostic Factors in Patients with Unknown Primary Tumors Treated with a Platinum-Based Combination 2005 ·Oncology ·Andrea Piga, Rosaria Gesuita, Vincenzo Catalano, Rolando Nortilli, Gianluigi Cetto, (unknown), (unknown), N. Riva, Emilio Porfiri, Rodolfo Montironi, Flavia Carle, R. Cellerino	8
7	High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy 2005 ·Annals of Oncology ·Francesco Pasini, Giovanni De Manzoni, Corrado Pedrazzani, Antonio Grandinetti, E Durante, (unknown), Anna Tomezzoli, C. Griso, Alfredo Guglielmi, Giuseppe Pelosi, Sergio Maluta, Gianluigi Cetto, Claudio Cordiano	35
8	Correlations between family history and cancer characteristics in 2256 breast cancer patients 2004 ·British Journal of Cancer ·A. Molino, Marco Giovannini, R. Pedersini, M. Frisinghelli, Rocco Micciolo, (unknown), Michele Pavarana, Gianluigi Cetto	22
9	Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods 1997 ·Breast Cancer Research and Treatment ·A. Molino, Rocco Micciolo, Monica Turazza, Franco Bonetti, Quirino Piubello, A. Corgnati, (unknown), (unknown), (unknown), Erminia Manfrin, Andrea Bonetti, Rolando Nortilli, Giovanni Paolo Pollini, (unknown), Gianluigi Cetto	52
10	Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen: A phase II study 1996 ·Cancer ·Diego Tummarello, Francesco Graziano, (unknown), Antonio Santo, Gianluigi Cetto, Anna Fedeli, G. Rossi, R. Cellerino	5
11	Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 1994 ·European Journal of Cancer ·Felice Pasini, (unknown), Antonio Santo, Gianluigi Cetto, Alberto Ambrosetti, (unknown), Vittorio Meneghini, G. Perona	14
12	High-dose chemotheraphy supported with autologous bone marrow transplantation (ABMT) in germ cell tumors: A phase two study 1992 ·Annals of Oncology ·Giovanni Rosti, (unknown), Roberto Salvioni, Giorgio Pizzocaro, Gianluigi Cetto, (unknown), M. Marangolo	17
13	Teniposide as single drug therapy for elderly patients affected by small cell lung cancer 1992 ·European Journal of Cancer ·Diego Tummarello, (unknown), Felice Pasini, Gianluigi Cetto, R. Cellerino	17
14	Oral ondansetron (GR38032F) for the control of acute and delayed cyclophosphamide-induced emesis. 1991 ·PubMed ·Raffaella Rosso, Elisabetta Campora, Gianluigi Cetto, Vinicio Fosser, M. Marangolo, Cristina Oliva	14
15	Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients. 1990 ·Journal of Clinical Oncology ·G Todeschini, Alberto Ambrosetti, Vittorio Meneghini, Giovanni Pizzolo, Fabio Menestrina, Marco Chilosi, Fabio Benedetti, Dino Veneri, Gianluigi Cetto, G. Perona	80
16	Ondansetron (GR38032) in the prophylaxis of acute and delayed cisplatin-induced emesis 1990 ·Clinical Oncology ·Fausto Roila, Sergio Bracarda, Maurizio Tonato, M. Marangolo, (unknown), Donatella Donati, Gianluigi Cetto, A. Del Favero	27
17	Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: Evaluation of cytotoxic events 1987 ·Leukemia Research ·Livio Trentin, Achille Ambrosetti, Renato Zambello, Carlo Agostini, M Masciarelli, Fabrizio Vinante, Marco Chilosi, Giovanni Pizzolo, Gianluigi Cetto, Gianpietro Semenzato	12
18	Terminal Transferase Expression in Relapsed Acute Myeloid Leukaemia 1981 ·British Journal of Haematology ·K. F. Bradstock, Giovanni Pizzolo, (unknown), Gianluigi Cetto, H. G. Prentice, K. Ganeshaguru, A. G. Prentice, A. G. Smith, Marco Chilosi, A. Ambrosetti, A. V. Hoffbrand	11
19	Acute Lymphoblastic Leukaemia after Radiotherapy and Adjuvant Chemotherapy (CMF) for Breast Cancer 1981 ·Acta Haematologica ·Giovanni Pizzolo, A. Molino, (unknown), Gianluigi Cetto, Antonio Iannucci, Marco Chilosi	10
20	A new method for the determination of sodium and potassium in human red blood cells, using indocyanine green as a marker for trapped plasma 1974 ·Clinica Chimica Acta ·L. Vettore, Giancarlo Falezza, (unknown), Gianluigi Cetto, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact